Literature DB >> 1730447

The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.

B L Kasiske1, M P O'Donnell, W F Keane.   

Abstract

Although the pathogenesis of obesity in OZR is unknown, the association among hyperinsulinemia, insulin resistance, and hyperlipidemia suggests that investigations using OZR may help define how a number of vascular disease risk factors interact to cause end-organ damage. Like other rat strains, OZR do not develop atherosclerosis spontaneously. Nevertheless, in an endothelial injury model, atherosclerosis was worse in OZR than in LZR. Perhaps more intriguing is the fact that OZR develop spontaneous glomerular injury. Although the mechanisms important in the development and progression of glomerular injury in OZR remain to be clarified, both lipid abnormalities and glomerular hemodynamic alterations could play a role.

Entities:  

Mesh:

Year:  1992        PMID: 1730447     DOI: 10.1161/01.hyp.19.1_suppl.i110

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  46 in total

1.  Upregulation of orexin receptor in paraventricular nucleus promotes sympathetic outflow in obese Zucker rats.

Authors:  Jing-Jing Zhou; Fang Yuan; Yi Zhang; De-Pei Li
Journal:  Neuropharmacology       Date:  2015-08-12       Impact factor: 5.250

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Blunted temporal activity of microvascular perfusion heterogeneity in metabolic syndrome: a new attractor for peripheral vascular disease?

Authors:  Joshua T Butcher; Adam G Goodwill; Shyla C Stanley; Jefferson C Frisbee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-21       Impact factor: 4.733

4.  Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.

Authors:  D J Baker; G P Wilkinson; A M Atkinson; H B Jones; M Coghlan; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

5.  Expression of gLTP in sympathetic ganglia of obese Zucker rats in vivo: molecular evidence.

Authors:  K H Alzoubi; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

6.  Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat.

Authors:  Yuriy Slyvka; Sharon R Inman; Ramiro Malgor; Edwin J Jackson; Jennifer Yee; Olusayo Oshogwemoh; John Adame; Felicia V Nowak
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

7.  Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.

Authors:  Katia Meirelles; Tamer Ahmed; Derek M Culnan; Christopher J Lynch; Charles H Lang; Robert N Cooney
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

8.  Metabolic syndrome and chronic kidney disease.

Authors:  D Bhowmik; S C Tiwari
Journal:  Indian J Nephrol       Date:  2008-01

9.  The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat.

Authors:  Carolyn M Ecelbarger; Arjun Rash; Rajesh K Sinha; Swasti Tiwari
Journal:  Mediators Inflamm       Date:  2010-05-17       Impact factor: 4.711

10.  The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats.

Authors:  Nahoko Sato; Masayuki Kaneko; Mitsutaka Tamura; Hajimu Kurumatani
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.